Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.44
+0.26 (3.18%)
May 20, 2026, 4:00 PM EDT - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $50.5 million as of May 20, 2026. Its market cap has increased by 40.69% in one year.
Market Cap
50.50M
Enterprise Value
-93.20M
1-Year Change
40.69%
Ranking
Category
Stock Price
$8.44
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $50.50M, a decrease of -88.17%. That is a compound annual growth rate of -37.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 50.50M | 50.24% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 56.72M |
| Instil Bio | 54.32M |
| KALA BIO | 54.19M |
| Gossamer Bio | 53.42M |
| iBio, Inc. | 52.77M |
| MiNK Therapeutics | 51.91M |
| Radiopharm Theranostics | 50.67M |
| Estrella Immunopharma | 49.07M |